KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Deferred Taxes: 2016-2024

Historic Deferred Taxes for BeOne Medicines (ONC) over the last 9 years, with Dec 2024 value amounting to $26.0 million.

  • BeOne Medicines' Deferred Taxes fell 102.74% to -$46,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $689,000, marking a year-over-year decrease of 66.54%. This contributed to the annual value of $26.0 million for FY2024, which is 3671.12% up from last year.
  • According to the latest figures from FY2024, BeOne Medicines' Deferred Taxes is $26.0 million, which was up 3,671.12% from $689,000 recorded in FY2023.
  • BeOne Medicines' 5-year Deferred Taxes high stood at $26.0 million for FY2024, and its period low was $261,000 during FY2020.
  • In the last 3 years, BeOne Medicines' Deferred Taxes had a median value of $2.1 million in 2022 and averaged $9.6 million.
  • Per our database at Business Quant, BeOne Medicines' Deferred Taxes slumped by 66.54% in 2023 and then skyrocketed by 3,671.12% in 2024.
  • Over the past 5 years, BeOne Medicines' Deferred Taxes (Yearly) stood at $261,000 in 2020, then spiked by 1,193.87% to $3.4 million in 2021, then slumped by 39.03% to $2.1 million in 2022, then tumbled by 66.54% to $689,000 in 2023, then skyrocketed by 3,671.12% to $26.0 million in 2024.